Non-small Cell Lung Cancer (NSCLC), Recurrent
1 clinical trials · Condition
◉ Watch Non-small Cell Lung Cancer (NSCLC), Recurrent
| Record | Firm | Date |
|---|---|---|
| Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC) (NCT01515969) | Heather Wakelee | 2012-07-01 |
Track Non-small Cell Lung Cancer (NSCLC), Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.